Top 6 Gait Training Robots in the UK for 2026
Published on Wednesday, 25 February 2026
Gait training robots are an innovative subset of rehabilitation robots within the Service Robots > Healthcare Robots category, designed to help patients relearn how to walk using advanced robotics, sensors and real-time feedback. In the UK, rising rates of age-related mobility impairment, stroke and neurological conditions have accelerated demand for these systems in NHS trusts, private clinics and specialist rehab centres. Consumers and clinicians favour gait training robots because they deliver high-intensity, repeatable practice tailored to individual recovery goals; reduce physical strain on therapists; and provide objective data to track progress. The appeal across UK markets comes from a mix of clinical effectiveness, improved patient engagement through interactive interfaces, and growing integration with digital health records and outcome measurement frameworks.
Top Picks Summary
Hocoma Lokomat Pro V6
The Lokomat Pro V6 is a cutting-edge robotic gait therapy solution that combines advanced robotics with innovative sensor technology to support rehabilitation for patients with walking difficulties. Its adaptive training capability allows for personalized therapy that grows with the patient's abilities, which sets it apart from traditional rehabilitation methods. With comprehensive feedback and data collection, clinicians can tailor interventions to individual needs, maximizing recovery potential. It represents the forefront of rehabilitation technology, ensuring patients receive the best care available.
Ekso Bionics EksoNR
EksoNR is a clinical-grade powered exoskeleton designed for intensive neurorehabilitation and is widely adopted in hospitals for its robust data capture and therapist-focused controls. It holds a market-leading position because its proven clinical outcomes, scalable training modes, and institutional-service model give it a strong ROI for clinics compared with lighter consumer devices; for the undefined use case, its versatility and rich analytics make it a conservative choice when requirements are unspecified. While typically more expensive than soft suits and treadmill systems, EksoNR’s durability and comprehensive support differentiate it from Toyota’s treadmill-oriented Welwalk, ReWalk’s soft-suit portability, and Cyberdyne’s intent-driven HAL system.
Toyota Welwalk WW-2000
The Welwalk WW-2000 is a treadmill-based gait trainer from Toyota that emphasizes repeatable, targeted step training with compact, clinic-friendly hardware and automated gait pattern adjustments. It stands out for cost-effectiveness and ease of installation relative to full exoskeleton systems, offering a pragmatic clinical solution for stroke and hemiparesis rehabilitation when the exact application is undefined. Compared with EksoNR’s wearable exoskeleton approach, Welwalk delivers high-throughput treadmill therapy at lower capital cost, while lacking the overground portability of ReWalk’s soft suit and the bioelectric intent control that Cyberdyne’s HAL provides.
Tyromotion TYMO
The TYMO is an interactive robotic therapy device that stands out for its gamified approach to rehabilitation. It combines advanced robotics with virtual reality elements to engage patients actively, making rehabilitation sessions more enjoyable and effective. This innovative focus on user experience encourages patient participation and satisfaction, which is essential for successful outcomes. The device is versatile in its applications, making it suitable for a broad range of rehabilitation scenarios.
ReWalk ReStore Soft Exo-Suit
ReStore is a soft, wearable exo-suit engineered for post-stroke gait assistance that prioritizes lightweight portability, user comfort, and lower acquisition and operating costs. For an undefined use case it is attractive because its softer architecture and simpler setup make it well suited to community and home use where rigid clinical systems may be impractical, and it typically enables faster deployment and broader patient access than larger clinic-only platforms. Technically it provides less rigid support than EksoNR or HAL but offers better daily-wear ergonomics and price-to-mobility benefits compared with treadmill-based solutions like the Welwalk.
Cyberdyne HAL Lower Limb
Cyberdyne’s HAL lower limb system uses bioelectrical signal detection and a cybernics control paradigm to provide assistive torque that is closely coupled to the user’s intent, promoting active engagement and potential neuroplastic gains. It occupies a distinct technical niche in this list because its intent-driven assistance can accelerate motor relearning compared to purely trajectory-driven systems, though it may demand more specialized training and carries regulatory and service considerations that influence total cost of ownership for an undefined application. Compared with EksoNR’s broad clinical workflow features, ReWalk’s soft-suit portability, and Welwalk’s treadmill efficiency, HAL’s primary advantage is its unique human–machine interface that targets patient-initiated movement.
What the research says about gait training robots
A growing body of clinical research supports the benefits of robotic gait training as a complement to conventional physiotherapy. Systematic reviews and randomized controlled trials show that, when combined with standard therapy, robotic systems can increase walking speed, step count and independence for selected patient groups. Evidence is strongest for subacute stroke and certain spinal cord injury profiles, while results vary by device type, intensity of training and patient selection. The technology appears to be safe when used in clinical settings and can improve therapy intensity and consistency, which are key drivers of neuroplastic recovery.
Systematic reviews and meta-analyses report modest but clinically meaningful improvements in walking speed and functional walking independence when robotic gait training is added to conventional therapy, especially after subacute stroke.
Randomized trials of treadmill-based systems (for example, devices like the Lokomat) show benefits in controlled clinical settings for repetitive, high-intensity stepping and gait symmetry training.
Overground exoskeletons and powered exosuits (such as Ekso, ReStore and HAL) have demonstrated gains in walking capacity and community ambulation for selected users with spinal cord injury and post-stroke hemiparesis in several clinical studies.
Soft exosuits and lighter wearable devices can reduce metabolic effort and improve paretic limb assistance during overground walking, which supports practical use outside the clinic.
Studies highlight the importance of individualized protocols, therapist involvement and supplementary conventional therapy to translate robotic gains into everyday mobility.
Safety profiles in clinical trials are generally favourable, with few serious adverse events reported when devices are used by trained clinicians under appropriate supervision.
Frequently Asked Questions
Which robot should clinics choose for neurorehab sessions?
Choose Ekso Bionics EksoNR for intensive neurorehabilitation, since it’s a clinical-grade powered bilateral exoskeleton for overground gait training with therapist controls and session data logging, rated 4.2.
Does the Hocoma Lokomat Pro V6 offer adaptive gait therapy?
Yes—Hocoma Lokomat Pro V6 includes adaptive training capability with personalised therapy programmes plus comprehensive training data analytics, and it has an average rating of 4.8.
Is Toyota Welwalk WW-2000 better value than exoskeleton options?
The Toyota Welwalk WW-2000 is described as cost-effective and easier to install than full exoskeletons, and it’s treadmill-based with real-time visual feedback, rated 4.5; no price is provided.
What warranty duration comes with these gait training robots?
The provided product data doesn’t include any warranty duration for Hocoma Lokomat Pro V6, Ekso Bionics EksoNR, or Toyota Welwalk WW-2000, so I can’t confirm warranty coverage.
Conclusion
Gait training robots are becoming a core tool for modern rehabilitation in the UK, offering data-driven, repeatable and engaging therapy for people recovering from stroke, spinal cord injury and other gait impairments. The six leading options highlighted here — Hocoma Lokomat Pro V6, Ekso Bionics EksoNR, Toyota Welwalk WW-2000, Tyromotion TYMO, ReWalk ReStore Soft Exo-Suit, and Cyberdyne HAL Lower Limb — cover a range of clinic-based and overground solutions. For most UK clinical settings in 2026, the Hocoma Lokomat Pro V6 stands out as the best overall choice because of its comprehensive gait analysis, adjustable support levels and strong integration into multidisciplinary rehab programs. If you did not find exactly what you need, you can refine or expand your search using the search box to compare devices by clinical indication, setting and budget. We hope you found what you were looking for.